Skip to content

Effect of bupivacaine liposome in nerve block

Effect of bupivacaine liposome in nerve block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097385
Enrollment
Unknown
Registered
2025-02-18
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Bupivacaine group (Group C):Bupivacaine is used for nerve blocking local anesthetic
Bupivacaine liposome group (Group D):Bupivacaine liposome is used for nerve blocking local anesthetic

Sponsors

Sir Run Run Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing nerve block surgery; 2. Patients aged 18-85 with complete clinical records; 3. American Society of Anesthesiologists (ASA) Anesthesia Risk Scale I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of allergy to the experimental drug; 2. Evidence of anesthesia contraindications; 3. Patients with heart, lung, liver, kidney, blood and other important system diseases; 4. Patients with communication or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Blood pressure;Heart rate;Blood oxygen saturation;Onset time of nerve block;Duration of nerve block;Dosage of postoperative analgesics;Postoperative pain score;

Secondary

MeasureTime frame
Nausea and vomiting;Postoperative adverse reaction;Postoperative recovery quality;

Countries

China

Contacts

Public ContactZheng Longbin

Sir Run Run Hospital Affiliated to Nanjing Medical University

272425852@qq.com+86 180 6175 0597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026